Madrigal has paid Pfizer $50 million for the rights to a DGAT2i inhibitor with the intention of combining the drug with its ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...

It’s CES 2026 week! That means more product launches than anyone knows what to do with. But that’s exactly why you read CNN Underscored — we combed the web (and the Las Vegas showroom floor) to find ...

Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...

Parabilis Medicines raised $305 million in a Series F round led by RA Capital, Fidelity and Janus Henderson, with crossover ...

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." ...

China’s human weight-loss drug market targeting GLP-1 receptors has heated up in recent years, with both global and domestic ...

Chinese automaker Xpeng said it wanted to become better known as a “physical AI” company rather than just a carmaker, as it ...

Ollin Biosciences’ VEGF/Ang2 bispecific antibody has shown superiority over Roche’s Vabysmo (faricimab) in a head-to-head ...

This week’s Apple headlines: iPhone 18 design warning, iPhone 17e release date, budget MacBook pricing, iOS 26 adoption rates ...

In this article, we will look at Virtus Convertible & Income Fund (NCV) and the opportunities that its preferred stock ...

The University of Michigan's consumer sentiment index climbed to 54.0 in January, recording its strongest reading since September 2025. Equities Trading UP. Rich Sparkle Holdings ...